Biotech | May 19, 2026
NunaBio secures £6.5 million to scale DNA manufacturing platform
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
The company says the platform offers improved manufacturability and functional advantages
This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Subscribe To Our Newsletter & Stay Updated
